Sildenafil citrate attenuates the deleterious effects of elevated ammonia

Toxicology Mechanisms and Methods

Volumn 23, Issue 6, 2013, Pages 402-411

  Arafa, Manar H ^a   Atteia, Hebatallah H ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

Antioxidants; CGMP; Hyperammonemia; Phosphodiesterase; Sildenafil

Indexed keywords

ALKALINE PHOSPHATASE; AMMONIUM CHLORIDE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NITRIC OXIDE; SILDENAFIL; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN; BRAIN FUNCTION; GENE EXPRESSION; HYPERAMMONEMIA; LIPID METABOLISM; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; UPREGULATION;

ACTINS; AMMONIUM CHLORIDE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BRAIN; CASPASE 3; GENE EXPRESSION; GLUTATHIONE; HYPERAMMONEMIA; LIPID PEROXIDATION; MALE; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONES;

RATTUS;

EID: 84879647752     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2013.770109     Document Type: Article

References (87)

1. Aebi H. (1984). Catalase in vitro. Methods Enzymol 105:121-26.
2. Ahmed AE, Gamal IH, Loh J, Abdel-Rahman SZ. (1991). Studies on mechanism of haloacetonitrile induced gastrointestinal toxicity, interaction of dibromoacetonitrile with glutathione as glutathiones- transferase in rats. J Biol Toxicol 612:115-21.
3. Albrecht J. (2007). Ammonia toxicity in the central nervous system. In: Lajtha A, Johnson A, Dianna A, eds. Handbook of neurochemistry and molecular neurobiology. Chapter 12. Berlin, Heidelberg: Springer- Verlag, 261-76.
4. Baynes JW. (1995). Reactive oxygen in the aetiology and complications of diabetes. In: Ioannides C, Flatt PR, eds. Drug diet and disease. Vol. 2. Mechanistic approach to diabetes. Hertfortshive: Ellis Horwood limited, 230-1.
5. Benito S, Lopez D, Sa'iz MP, et al. (2002). A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 135:910-16.
6. Burton GW. (1994). Vitamin E: molecular and biological function. Proc Nutr Soc 53:251-62.
7. Cadirci E, Halici Z, Odabasoglu F, et al. (2011). Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study. Clin Exp Immunol 166:374-84.
8. Cagnon L, Braissant O. (2008). Role of caspases, calpain and cdk5 in ammonia-induced cell death in developing brain cells. Neurobiol Dis 32:281-92.
9. Carr TP, Andresen CJ, Rudel LL. (1993). Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26:39-42.
10. Chepkova AN, Sergeeva OA, Haas HL. (2006). Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment. Neurobiol Dis 23:512-21.
11. Chomkczynski P, Sacchi N. (1987). Single step method for RNA isolation by the acid guanidinum thiocyanate phenol chloroform methods. Anal Biochem 162:156-60.
12. Chromy V, Fischer J. (1977). Photometric determination of total protein in lipemic sera. Clin Chem 23:754-6.
13. Chuang AT, Strauss JD, Murphy RA, Steers WD. (1998). Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 160:257-61.
14. Ciani E, Guidi S, Bartesaghi R, Contestabile A. (2002). Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide. J Neurochem 82:1282-9.
15. Corbala'n R, Chatauret N, Behrends S, et al. (2002). Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients. Hepatology 36:1155-62.
16. Dakshayani KB, Velvizhi S, Subramanian P. (2002). Effects of ornithine alpha ketoglutarate on circulatory antioxidants and lipid peroxidation products in ammonium acetate treated rats. Ann Nutr Metab 46:93-6.
17. Deshmukh DR, Deshmukh GD, Shope TC, Radin NS. (1983). Free fatty acids in an animal model of Reye's syndrome. Biochim Biophys Acta 753:153-8.
18. Domek-Łopacin'ska K, Strosznajder JB. (2005). Cyclic GMP metabolism and its role in brain physiology. J Physiol Pharmacol 56:15-34.
19. Ebrahimi F, Shafaroodi H, Asadi S, et al. (2009). Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism. Can J Physiol Pharmacol 87:556-64.
20. El-Metwally MA, Sharabi FM, Daabees TT, et al. (2007). Involvement of alpha-receptors and potassium channels in the mechanism of action of sildenafil citrate. Int J Impot Res 19:551-7.
21. Erceg S, Monfort P, Hernandez-Viadel M, et al. (2005a). Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain. Brain Res 1036:115-21.
22. Erceg S, Monfort P, Herna'ndez-Viadel M, et al. (2005b). Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 41:299-306.
23. Essa MM, Ali AA, Waly MI, et al. (2010). Effect of leaves on serum lipids in ammonium chloride induced experimental hyperammonemic rats Pongamia pinnata. Int J Biol Med Res 1:71-3.
24. Essa MM, Subramanian P. (2006). Pongamia pinnata modulates oxidantantioxidant imbalance during hyperammonemic rats. Fundam Clin Pharmacol 20:299-303.
25. Essa MM, Subramanian P, Suthakar G, et al. (2005). Protective influence of Pongamia pinnata (Karanja) on blood ammonia and urea levels in ammonium chloride induced hyperammonemia. J Appl Biomed 3263:13-24.
26. Fayed AH, Gad SB. (2011). Effect of sildenafil citrate (Viagra-) on trace element concentration in serum and brain of rats. J Trace Elem Med Biol 25:236-8.
27. Felipo V. (2006). Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy. World J Gastroenterol 12:7737-43.
28. Feng G, Masao S, Hideaki N. (2005). Phosphodiestrase 5 inhibitor, zaprinast, selectively increases cerebral blood flow in the ischemic penumbra in the rat brain. Neurol Res 27:638-43.
29. Fossati P, Prencipe L. (1982). Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-80.
30. Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
31. Gopal VK, Francis SH, Corbin JD. (2001). Allosteric sites of phosphodiestrase-5 (PDE-5). Eur J Biochem 268:3304-12.
32. Gordon SA, Fleck A, Bell J. (1978). Optimal conditions for the estimation of ammonium by the Berthelot reaction. Ann Clin Biochem 15:270-5.
33. Grove TH. (1979). Effect of reagent pH on determination of HDL cholesterol by precipitation with sodium phosphotungestate-magnesium. Clin Chem 25:560-4.
34. Guazzi M, Samaja M. (2007). The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development. Curr Med Chem 14:1893-910.
35. Haberle J. (2011). Clinical practice: the management of hyperammonemia. Eur J Pediatr 170:21-34.
36. Hall CN, Attwell D. (2008). Assessing the physiological concentrations and targets of nitric oxide in brain tissue. J Physiol 586:3597-615.
37. Halliwell B. (2001). Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685-716.
38. Henderson AR, Moss DW. (2001). Enzymes. In: Burits CA, Ashwood ER, eds. Tietz fundamentals of clinical chemistry. 5th ed. Philadelphia: W.B. Saunders Company, 352.
39. Hwang DF, Wang LC. (2001). Effect of taurine on toxicity of cadmium in rats. Toxicology 167:173-80.
40. Hwu W, Chiang SC, Chang MH, Wang TR. (2000). Carnitine transport defect presenting with hyperammonemia: report of one case. Chung Hua Min Muo Hsiao Erh Ko I Heueh Hui Tsa Chih 41:36-8.
41. Karatza AA, Bush A, Magee AG. (2005). Safety and efficacy of sildenafil therapy in children with pulmonary hypertension. Int J Cardiol 100:267-73.
42. Kim BJ, Ryu SW, Song BJ. (2006). JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 281:21256-65.
43. Kojda G, Kottenbery K, Nix P, et al. (1996). Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78:91-101.
44. Kone BC. (2004). Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health. Semin Nephrol 24:299-315.
45. Kosenko E, Kaminsky A, Valencia M, et al. (1997). Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res 27:637-44.
46. Larsen FS. (2002). Cerebral blood flow in hyperammonemia: heterogeneity and starling forces in capillaries. Metab Brain Dis 17:229-35.
47. Lena PJ, Subramanian P. (2003). Evaluation of the antiperoxidative effects of melatonin in ammonium acetate-treated Wistar rats. Pol J Pharmacol 55:1031-6.
48. Lena PJ, Subramanian P. (2004). Effects of melatonin on the levels of antioxidants and lipid peroxidation products in rats treated with ammonium acetate. Pharmazie 59:636-9.
49. Lin CS, Lin G, Xin ZC, Lue TF. (2006). Expression, distribution and regulation of phosphodiestrase 5. Curr Pharm Des 12:3439-57.
50. Lucas KA, Pitari GM, Kazerounian S, et al. (2000). Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 53:375-414.
51. Mahmoud AM. (2012). Influence of rutin on biochemical alterations in hyperammonemia in rats. Exp Toxicol Pathol 64:783-9.
52. Majeed KI. (2005). Hyperammonemia is associated with an increase in inhibitory neurotransmission as a consequence of two factors. E Med J 2:12-15.
53. Maranón E, Ulmanub M, Fernándeza Y, et al. (1996). Removal of ammonium from aqueous solutions with volcanic tuff. J Hazard Mater 137:1402-9.
54. Mates JM, Perez-Gomez C, De Castro IN. (1999). Antioxidant enzymes and human diseases. Clin Biochem 32:595-603.
55. Mathias RS, Kostiner D, Packman S. (2001). Hyperammonemia in urea cycle disorders: role of the nephrologist. Am J Kidney Dis 37:1069-80.
56. Meiattini F, Prencipe L, Bardelli F, Giannini G. (1978). The 4- hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymatic determination of serum cholesterol. Clin Chem 24:2161-5.
57. Moshage H, Kok B, Heuzenga JR, Jansen PL. (1995). Nitrite and nitrate determination in plasma: a critical evaluation. Clin Chem 41:892-6.
58. Munro S, Maniatis T. (1989). Expression cloning of the murine interferon gamma receptor cDNA. Proc Natl Acad Sci USA 86:9248-52.
59. Murthy CR, Rama Rao KV, Bai G, Norenburg MD. (2001). Ammonia induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 66:282-8.
60. Nelson DL, Cox MM. (2000). Lehninger principles of biochemistry. London: W.H. Freeman Publisher.
61. Nishikimi M, Roa NA, Yogi K. (1972). The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Bioph Res Common 46:849-54.
62. Ockaili R, Salloum F, Hawkins J, Kukreja RC. (2002). Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol 283:H1263-9.
63. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-8.
64. Paglia DE, Valentine WN. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-69.
65. Puerta E, Barros-Minones L, Hervias I, et al. (2012). Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain. J Neurosci Res 90:518-28.
66. Rajesh MG, Latha MS. (2004). Preliminary evaluation of antihepatotoxic activity of Kamilari, a poly herbal formulation. J Ethnopharmacol 91:99-104.
67. Rodrigo R, Jover R, Candela A, et al. (2005). Bile duct ligation plus hyperammonemia in rats reproduces the alterations in the modulation of soluble guanylate cyclase by nitric oxide in brain of cirrhotic patients. Neuroscience 130:435-43.
68. Rosalki SB, Foo AY, Burlina A, et al. (1993). Multicenter evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clin Chem 39:648-52.
69. Rupinder SK, Gurpreet AK, Manjeet S. (2007). Cell suicide and caspases. Vascul Pharmacol 46:383-93.
70. Sagud M, Mihaljevic-Peles A, Pivac N, et al. (2009). Lipid levels in female patients with affective disorders. Psychiatry Res 168:218-21.
71. Smith S, Dringenberg HC, Bennett BM, et al. (2000). A novel nitrate ester reverses the cognitive impairment caused by scopolamine in the Morris water maze. Neuro Rep 11:3883-6.
72. Steinberg D, Parathasarathy S, Carew TE, et al. (1989). Modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 320:915-18.
73. Subash S, Subramanian P. (2009). Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study. Mol Cell Biochem 327:153-61.
74. Subash S, Subramanian P. (2011). Impact of morin (a bioflavonoid) on ammonium chloride-mediated oxidative damage in rat kidney. Int J Nutr Pharmacol Neurol Dis 1:174-8.
75. Subash S, Subramanian P. (2012). Protective effect of morin on lipid peroxidation and lipid profile in ammonium chloride-induced hyperammonemic rats. Asian Pac J Trop Dis 2:103-6.
76. Thippeswamy T, McKay JS, Quinn JP, Morris R. (2006). Nitric oxide, a biological double-faced janus - is this good or bad? Histol Histopathol 21:445-58.
77. Velvizhi S, Dakshayani KB, Subramanian P. (2002). Protective influences of alpha-keto glutarate on lipid peroxidation and antioxidant status ammonium acetate rats. Ind J Exp Biol 40:1183-6.
78. Vijayakumar N, Subramanian P. (2010). Neuroprotective effect of Semecarpus anacardium against hyperammonemia in rats. J Pharm Res 3:1564-68.
79. Walker DK, Ackland MJ, James GC, et al. (1999). Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 29:297-310.
80. Wang S, Gaylord BS, Bazan GC. (2004). Fluorescein provides a resonance gate for FRET from conjugated polymers to DNA intercalated dyes. J Am Chem Soc 126:5446-51.
81. Williams BA, Liu C, Deyoung L, et al. (2005). Regulation of intracellular Ca2 release in corpus cavernosum smooth muscle: synergism between nitric oxide and cGMP. Am J Physiol Cell Physiol 288:C650-8.
82. Wolin M. (2000). Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20:1430-42.
83. Yang L, Omori K, Suzukawa J, Inagaki C. (2004). Calcineurin-mediated BAD Ser155 dephosphorylation in ammonia-induced apoptosis of cultured rat hippocampal neurons. Neurosci Lett 357:73-7.
84. Yldz H, Durmus AS, Sims-ek H, Yaman M. (2012). Dose-dependent protective effect of sildenafil citrate on testicular injury after torsion/ detorsion in rats. Andrologia 44:300-6.
85. Zapp K-H, Wostbrock K-H, Schafer M, et al. (2012). Ullmann's encylopedia of industrial chemistry book. Weinheim: Wiley-VCH.
86. Zhang RL, Zhang Z, Zhang L, et al. (2006). Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res 83:1213-19.
87. Zielin'ska M, Fresko I, Konopacka A, et al. (2007). Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices. Neurotoxicology 28:1260-3.